Friday, March 16, 2018 12:32:34 PM
B may get BTD. We have a meeting with the FDA. That could be next week or next month. And they may say no BTD but keep going to Phase 3. I'm very confident of the latter, for sure. There was pretty clear efficacy signal, and OM needs therapy options. They may say BTD. We'll see.
The P 2B is taking longer than expected to wrap up. Not unusual. Jury out, and company has no clue on results. Don't listen to anyone who says otherwise. They are truly clueless.
K needs a pill. We had to abandon our 2A because the dosing was inadequate and cash is tight. We even had to lay people off and cut Menon's pay.
Hang in there everyone. If you thought biotech was a short walk in the park, everything can be a learning experience.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM